🇺🇸 FDA
Pipeline program

A clinical trial of MK-4605 in healthy participants (MK-4605-001)

MK-4605-001

Phase 1 other active

Quick answer

A clinical trial of MK-4605 in healthy participants (MK-4605-001) for Dementia is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Dementia
Phase
Phase 1
Modality
other
Status
active

Clinical trials